Effect of zwitterionic sulfobetaine incorporation on blood behaviours, phagocytosis, and <i>in vivo</i> biodistribution of pH-responsive micelles with positive charges-Reference-Cited by-全球学者库

Effect of zwitterionic sulfobetaine incorporation on blood behaviours, phagocytosis, and in vivo biodistribution of pH-responsive micelles with positive charges

Published:2024 Issue: Volume: Page:
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Wang Chengwei¹^ORCID,Liu Hao²,Lin Hu³,Zhong Rui⁴,Li Hao²,Liu Jiaxin⁴,Luo Xianglin³,Tian Meng²^ORCID

Affiliation:

1. Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China

2. Department of Neurosurgery and Neurosurgery Research Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China

3. College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu 610065, P. R. China

4. Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, 610052, P. R. China

Abstract

A series of pH-responsive and sulfobetaine-incorporated micelles with positive charges is prepared, in which the effects of the sulfobetaine incorporation displayed different profiles in the blood behaviours, phagocytosis, and in vivo biodistribution.

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Chinese Academy of Medical Sciences

Peking Union Medical College

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D3TB02477F

Reference56 articles.

1. Osteonecrosis of the Femoral Head

2. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy

3. Rational construction of polycystine-based nanoparticles for biomedical applications

4. Stimuli‐Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy

5. Recent advances in pH-responsive nanomaterials for anti-infective therapy